| |
Alpha This system is experimental. Scores and classifications are early-stage research and may be unreliable. Methodology → |
|
| Summary ~lite The article discusses the potential growth and benefits of GLP-1 medications like Ozempic in the US market.
Lite evaluation by llama-4-scout-wai-psq · editorial channel only · no per-section breakdown available
| |
Longitudinal
· 2 evals | |
Audit Trail
5 entries | 2026-03-14 00:56 | eval_success | PSQ evaluated: g-PSQ=0.440 (3 dims) | - - | | 2026-03-14 00:56 |
eval
|
Evaluated by llama-4-scout-wai-psq: +0.44 (Moderate positive) | | | 2026-03-14 00:52 | eval_success | Lite evaluated: Neutral (-0.10) | - - | | 2026-03-14 00:52 |
eval
|
Evaluated by llama-4-scout-wai: -0.10 (Neutral) | | | reasoning The article discusses the potential benefits and usage of GLP-1 drugs like Ozempic, with no explicit human rights discus | | 2026-03-14 00:52 | rater_validation_warn | Lite validation warnings for model llama-4-scout-wai: 1W 1R | - - | | |
| |